Current Affairs Coronavirus Thread - Serious stuff !!!

Status
Not open for further replies.
How do you know its good, if you question the judgement of the body that approved it?
The regulator in this case (the MHRA - funded by UK Government) is sitting in judgement of a vaccine created with the backing of the UK government. If they were sitting in judgement of Pfizer, Moderna or Johnson and Johnson's vaccines there'd be less conflict of interest.
 
The regulator in this case (the MHRA - funded by UK Government) is sitting in judgement of a vaccine created with the backing of the UK government. If they were sitting in judgement of Pfizer, Moderna or Johnson and Johnson's vaccines there'd be less conflict of interest.

But they have sat in judgement of the Pfizer one, and said its fine.

And the Oxford vax hasnt been developed by the Government. They have provided, I assume, cash, but it will go though the exact same MHRA process. Unless Ihave missed sommet.
 
But they have sat in judgement of the Pfizer one, and said its fine.

And the Oxford vax hasnt been developed by the Government. They have provided, I assume, cash, but it will go though the exact same MHRA process. Unless Ihave missed sommet.
They ok'd the Pfizer one and other regulatory bodies will too. They have zero links to the agents of those other vaccines and cant do other than give an objective evaluation. Can they do that for a vaccine that's produced by their own employers? The government have invested money and credibility into it.

We'll soon see.

The sketchy data they have right now, especially that concerning older age groups, look very unconvincing to be passing it.
 
They ok'd the Pfizer one and other regulatory bodies will too. They have zero links to the agents of those other vaccines and cant do other than give an objective evaluation. Can they do that for a vaccine that's produced by their own employers? The government have invested money and credibility into it.

We'll soon see.

The sketchy data they have right now, especially that concerning older age groups, look very unconvincing to be passing it.

There is zero chance that if the OU/GS vax isnt safe that it will get approved.

I have no idea what sketchy data they have provided, but given that the development has been by Oxford University and a giant pharma, I am reasonably confident it will be robust.

The virus is a new one, but it isnt the first one.
 
That'll take a few months...hopefully by that time the vulnerable will have been vaccinated with a dose that works so they dont have to use it.
My guess ( and its just my guess ) is they wont be giving the double dose out at all.
Not when then half/ full dose is much more effective.
The double dose is classed as safe to go , but obviously with the roll out being the vulnerable , elderly & the care services first to be vaccinated its the right way to hold back til the half/ full dose is ready to roll.
Its the correct way to do it.
 
They ok'd the Pfizer one and other regulatory bodies will too. They have zero links to the agents of those other vaccines and cant do other than give an objective evaluation. Can they do that for a vaccine that's produced by their own employers? The government have invested money and credibility into it.

We'll soon see.

The sketchy data they have right now, especially that concerning older age groups, look very unconvincing to be passing it.
There is no "sketchy data "
All the info I have seen is perfectly fine for a general vaccine.
The only other point is by accident they found it much better in a smaller dose and rightly so it was trialed in the upto 55 age group and quite rightly not to the vulnerable & elderly until its considered safe in the younger group , same as they have done with pregnant woman and children.
Of course this will take longer to pass , but it certainly is not " sketchy data ".
 
There is zero chance that if the OU/GS vax isnt safe that it will get approved.

I have no idea what sketchy data they have provided, but given that the development has been by Oxford University and a giant pharma, I am reasonably confident it will be robust.

The virus is a new one, but it isnt the first one.
It's safe, it's just whether its efficacious enough to give to vulnerable people. That's the issue.
 
My guess ( and its just my guess ) is they wont be giving the double dose out at all.
Not when then half/ full dose is much more effective.
The double dose is classed as safe to go , but obviously with the roll out being the vulnerable , elderly & the care services first to be vaccinated its the right way to hold back til the half/ full dose is ready to roll.
Its the correct way to do it.
The Oxford vaccine isn't convincing the scientific community over its effectiveness for all age groups - the older age group in particular.
 
Well lets wait and see what the folk who know what they are on about decide. Thats the issue.
More testing for the Oxford vaccine. I think they know their figures dont look convincing.

If it was just restrcited to the under 65s then I wouldn't see that as a major problem. But their best efforts look well short of offering protection to the very elderly - and that's the major objective of these vaccines: to protect those most in danger from the virus.
 
The Oxford vaccine isn't convincing the scientific community over its effectiveness for all age groups - the older age group in particular.
Thats pretty much what i said apart from "isnt convincing the science cummunity "as you put it.
Once the assurances for the elderly are met it will be rolled out.
Its safety measure , and the right way to do it.
 
Status
Not open for further replies.

Welcome

Join the Everton conversation today.
Fewer ads, full access, completely free.

🛒 Visit Shop

Support Grand Old Team by checking out our latest Everton gear!
Back
Top